Document is current

Article History

Accepted: 1 July 2024

First Online: 28 August 2024

Declarations

:

: This study was funded by Janssen Pharmaceuticals. The sponsor was involved in the study design but had no role in data collection, data analysis, data interpretation, or writing of the statistical report. All authors had full access to the study data and had final responsibility for the decision to submit this article for publication. Medical writing was provided by Jacqueline Janowich Wasserott (Evidera) and was funded by Janssen.

: A. Keenan: conceptualization, methodology, software, writing—original draft, writing—review and editing, supervision. C. Whichello: conceptualization, methodology, validation, formal analysis, investigation, data curation, writing—original draft, writing—review and editing, visualization, supervision, project administration. H.H. Lee: conceptualization, methodology, writing—original draft, writing—review and editing, supervision. D.M. Kern: conceptualization, methodology, writing—review and editing, supervision. G. Fernandez: conceptualization, methodology, validation, investigation, data curation, writing—original draft, writing—review and editing, project administration. V. Turner: methodology, validation, investigation, data curation, writing—original draft, writing—review and editing. A. Das: methodology, validation, formal analysis, investigation, data curation, writing—review and editing, visualization. M. Quaife: conceptualization, methodology, validation, formal analysis, investigation, data curation, writing—original draft, writing—review and editing, supervision. A. Perrin Ross: conceptualization, writing—review and editing.

: C.W., G.F., V.T., A.D., and M.Q. are employees of Evidera, which received funding from Janssen to conduct this study. A.K., H.H.L., and D.M.K. are employees of Janssen and may own Johnson & Johnson stocks. A.P.R. reports having received consulting fees from EMD Serono, BMS, Novartis, Janssen, Genzyme, Horizon, Alexion, TG Therapeutics, Roche, and Merke as well as payments or honoraria for lectures, presentations, speakers’ bureaus, manuscript writing, or educational events from EMD Serono, BMS, Novartis, Genzyme, Horizon, Alexion, and TG Therapeutics.

: The informed consent obtained from participants does not allow for individual data to be made publicly available.

: The study was approved by Ethical and Independent Review Services (nos. 22022-01 and 22022-01A). Upon completion of the study, each participant was remunerated for their time with a cash equivalent in panel currency/voucher.

: Participants provided their consent to participant in the study and have their anonymized data included in subsequent publications through an online informed consent form, approved by the Ethical and Independent Review Services (nos. 22022-01 and 22022-01A).

: The datasets generated during and/or analyzed during the current study are not publicly available as no consent was sought from participants to allow sharing of data with third parties.